<DOC>
	<DOCNO>NCT01646788</DOCNO>
	<brief_summary>The purpose study demonstrate safety effectiveness use NMB 's percutaneous transluminal angioplasty ( PTA ) treatment obstructive lesion Arteriovenous ( AV ) Dialysis Fistulae/Grafts .</brief_summary>
	<brief_title>Study NMB Drug Ejecting Balloon Arteriovenous Fistulae</brief_title>
	<detailed_description />
	<mesh_term>Fistula</mesh_term>
	<mesh_term>Arteriovenous Fistula</mesh_term>
	<mesh_term>Paclitaxel</mesh_term>
	<criteria>1 . Patient 18 year old old . 2 . Native arteriovenous fistula synthetic arteriovenous access graft performed/implanted 45 day enrollment least one successful hemodialysis session perform . 3 . Patient obstructive lesion native synthetic arteriovenous dialysis fistulae/grafts , suitable PTA procedure . 4 . Patient willing able sign write informed consent complies procedure ( include adherence followup visit ) . 1 . Women pregnant breastfeed woman childbearing potential use adequate contraception . 2 . Previous participation another study investigational drug device within past 30 day . 3 . Life expectancy le 12 month factor make clinical and/or angiographic followup difficult . 4 . Known hypersensitivity paclitaxel structurallyrelated compound . 5 . Severe reaction contrast agent adequately premedicated prior procedure . 6 . Stenosis correspond thrombosis treat within 7 day enrollment . 7 . Patient known contraindication aspirin anticoagulant/antiplatelet therapy . 8 . Infected grafts/fistulae .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>July 2012</verification_date>
</DOC>